These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37386821)

  • 1. DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-
    Tae HS; Ortells MO; Tekarli BJ; Manetti D; Romanelli MN; McIntosh JM; Adams DJ; Arias HR
    ACS Chem Neurosci; 2023 Jul; 14(14):2537-2547. PubMed ID: 37386821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABA
    Tae HS; Ortells MO; Yousuf A; Xu SQ; Akk G; Adams DJ; Arias HR
    Biochem Pharmacol; 2024 May; 223():116183. PubMed ID: 38580167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of α4β2, α7 and α9α10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro.
    Koval L; Lykhmus O; Zhmak M; Khruschov A; Tsetlin V; Magrini E; Viola A; Chernyavsky A; Qian J; Grando S; Komisarenko S; Skok M
    Int J Biochem Cell Biol; 2011 Apr; 43(4):516-24. PubMed ID: 21146628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic antidepressants inhibit hippocampal α7* and α9α10 nicotinic acetylcholine receptors by different mechanisms.
    Arias HR; Vázquez-Gómez E; Hernández-Abrego A; Gallino S; Feuerbach D; Ortells MO; Elgoyhen AB; García-Colunga J
    Int J Biochem Cell Biol; 2018 Jul; 100():1-10. PubMed ID: 29704625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.
    Indurthi DC; Pera E; Kim HL; Chu C; McLeod MD; McIntosh JM; Absalom NL; Chebib M
    Biochem Pharmacol; 2014 May; 89(1):131-40. PubMed ID: 24548457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization.
    Moretti M; Zoli M; George AA; Lukas RJ; Pistillo F; Maskos U; Whiteaker P; Gotti C
    Mol Pharmacol; 2014 Sep; 86(3):306-17. PubMed ID: 25002271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
    McIntosh JM; Plazas PV; Watkins M; Gomez-Casati ME; Olivera BM; Elgoyhen AB
    J Biol Chem; 2005 Aug; 280(34):30107-12. PubMed ID: 15983035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT
    Arias HR; Rudin D; Hines DJ; Contreras A; Gulsevin A; Manetti D; Anouar Y; De Deurwaerdere P; Meiler J; Romanelli MN; Liechti ME; Chagraoui A
    Eur J Pharmacol; 2024 Mar; 966():176329. PubMed ID: 38253116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New quinoline derivatives as nicotinic receptor modulators.
    Manetti D; Bellucci C; Dei S; Teodori E; Varani K; Spirova E; Kudryavtsev D; Shelukhina I; Tsetlin V; Romanelli MN
    Eur J Med Chem; 2016 Mar; 110():246-58. PubMed ID: 26840365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying the binding site of novel methyllycaconitine (MLA) analogs at α4β2 nicotinic acetylcholine receptors.
    Quek GX; Lin D; Halliday JI; Absalom N; Ambrus JI; Thompson AJ; Lochner M; Lummis SC; McLeod MD; Chebib M
    ACS Chem Neurosci; 2010 Dec; 1(12):796-809. PubMed ID: 22778816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of rat α9α10 nicotinic acetylcholine receptor with α-conotoxin RgIA and Vc1.1: Insights from docking, molecular dynamics and binding free energy contributions.
    Li R; Li X; Jiang J; Tian Y; Liu D; Zhangsun D; Fu Y; Wu Y; Luo S
    J Mol Graph Model; 2019 Nov; 92():55-64. PubMed ID: 31330438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key role of the TM2-TM3 loop in calcium potentiation of the α9α10 nicotinic acetylcholine receptor.
    Gallino SL; Agüero L; Boffi JC; Schottlender G; Buonfiglio P; Dalamon V; Marcovich I; Carpaneto A; Craig PO; Plazas PV; Elgoyhen AB
    Cell Mol Life Sci; 2024 Aug; 81(1):337. PubMed ID: 39120784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule ligands for α9 * and α7 nicotinic receptors: A survey and an update, respectively.
    Giraudo A; Pallavicini M; Bolchi C
    Pharmacol Res; 2023 Jul; 193():106801. PubMed ID: 37236412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors.
    Innocent N; Livingstone PD; Hone A; Kimura A; Young T; Whiteaker P; McIntosh JM; Wonnacott S
    J Pharmacol Exp Ther; 2008 Nov; 327(2):529-37. PubMed ID: 18664588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of Compound Targeting α7 and β2 Subunits in Nicotinic Acetylcholinergic Receptor.
    Singh K; Ngo A; Keerthisinghe OV; Patel KK; Liang C; Mukherjee J
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analogs of α-conotoxin PnIC selectively inhibit α7β2- over α7-only subtype nicotinic acetylcholine receptors via a novel allosteric mechanism.
    George AA; John SJ; Lucero LM; Eaton JB; Jaiswal E; Christensen SB; Gajewiak J; Watkins M; Cao Y; Olivera BM; Im W; McIntosh JM; Whiteaker P
    FASEB J; 2024 Jan; 38(1):e23374. PubMed ID: 38161283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.
    Christensen SB; Bandyopadhyay PK; Olivera BM; McIntosh JM
    Biochem Pharmacol; 2015 Aug; 96(4):349-56. PubMed ID: 26074268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10.
    Zakrzewicz A; Richter K; Agné A; Wilker S; Siebers K; Fink B; Krasteva-Christ G; Althaus M; Padberg W; Hone AJ; McIntosh JM; Grau V
    Front Cell Neurosci; 2017; 11():189. PubMed ID: 28725182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of nanobodies acting as silent and positive allosteric modulators of the α7 nicotinic acetylcholine receptor.
    Li Q; Nemecz Á; Aymé G; Dejean de la Bâtie G; Prevost MS; Pons S; Barilone N; Baachaoui R; Maskos U; Lafaye P; Corringer PJ
    Cell Mol Life Sci; 2023 May; 80(6):164. PubMed ID: 37231269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.